Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

GMP Audit Findings

Essential SOPs for Regulatory Inspection Readiness in Pharma

Posted on By

Essential SOPs for Regulatory Inspection Readiness in Pharma Establishing SOPs for Regulatory Inspection Preparedness in Pharma Introduction to the Audit Finding 1. Background Pharmaceutical companies must be audit-ready at all times. However, lack of a formal SOP for preparing for regulatory inspections is a common GMP gap. 2. Why This Is Critical Without a written…

Read More “Essential SOPs for Regulatory Inspection Readiness in Pharma” »

GMP Audit Findings, Inspection Readiness

Lack of Documented Roles During Inspection Events in Pharma

Posted on By

Lack of Documented Roles During Inspection Events in Pharma Clarifying Roles During GMP Inspections: A Crucial Element of Audit Readiness Introduction to the Audit Finding 1. Background In many pharmaceutical audits, a frequent finding is the absence of clearly documented roles and responsibilities during inspection events. This reflects a lack of organizational preparedness. 2. Regulatory…

Read More “Lack of Documented Roles During Inspection Events in Pharma” »

GMP Audit Findings, Inspection Readiness

No Procedure for Document Retrieval During Audits: A GMP Compliance Risk

Posted on By

No Procedure for Document Retrieval During Audits: A GMP Compliance Risk Managing Audit Documentation: Why You Need SOPs for Inspection-Day Document Retrieval Introduction to the Audit Finding 1. The Compliance Gap Pharmaceutical sites often face audit findings due to the absence of defined procedures for retrieving GMP documents during inspections. This delay in document presentation…

Read More “No Procedure for Document Retrieval During Audits: A GMP Compliance Risk” »

GMP Audit Findings, Inspection Readiness

Outdated Site Master File Presented During Inspection: A GMP Readiness Concern

Posted on By

Outdated Site Master File Presented During Inspection: A GMP Readiness Concern GMP Inspection Risk: Outdated Site Master File Undermines Audit Readiness Introduction to the Audit Finding 1. The Problem During GMP inspections, presenting an outdated or obsolete version of the Site Master File (SMF) is a critical gap. It indicates weak document control and poor…

Read More “Outdated Site Master File Presented During Inspection: A GMP Readiness Concern” »

GMP Audit Findings, Inspection Readiness

Failure to Brief Staff on SOPs Ahead of Inspection: A Risk to GMP Audit Readiness

Posted on By

Failure to Brief Staff on SOPs Ahead of Inspection: A Risk to GMP Audit Readiness Staff Not Briefed on SOPs Before Audit: A Common Compliance Oversight Introduction to the Audit Finding 1. Audit Day Exposure During regulatory inspections, unprepared staff unable to answer questions related to standard operating procedures (SOPs) is a recurring issue. 2….

Read More “Failure to Brief Staff on SOPs Ahead of Inspection: A Risk to GMP Audit Readiness” »

GMP Audit Findings, Inspection Readiness

SOPs Lacking Definition of Critical vs. Non-Critical Deviations: A Hidden GMP Risk

Posted on By

SOPs Lacking Definition of Critical vs. Non-Critical Deviations: A Hidden GMP Risk Missing Clarity in Deviation SOPs: How Undefined Deviation Severity Risks GMP Compliance Introduction to the Audit Finding 1. What’s the Issue? Many GMP facilities have deviation SOPs that don’t clearly differentiate between critical and non-critical deviations. This can delay risk assessment and cause…

Read More “SOPs Lacking Definition of Critical vs. Non-Critical Deviations: A Hidden GMP Risk” »

Deviation Handling, GMP Audit Findings

Inconsistent Deviation Documentation Procedures: Undermining GMP Data Integrity

Posted on By

Inconsistent Deviation Documentation Procedures: Undermining GMP Data Integrity Deviation Documentation Lapses: A Threat to GMP Traceability and Compliance Introduction to the Audit Finding 1. Nature of the Finding Inconsistent documentation of deviations — including incomplete forms, missing justifications, or unsigned entries — is a serious GMP non-compliance risk. 2. Where It Occurs This issue is…

Read More “Inconsistent Deviation Documentation Procedures: Undermining GMP Data Integrity” »

Deviation Handling, GMP Audit Findings

Absence of SOP for Deviation Trending: A Missed Opportunity in GMP Oversight

Posted on By

Absence of SOP for Deviation Trending: A Missed Opportunity in GMP Oversight Why Deviation Trending Must Be an SOP Requirement in GMP Systems Introduction to the Audit Finding 1. Nature of the Finding The absence of SOP guidance on how to trend deviations — by type, frequency, department, or root cause — results in poor…

Read More “Absence of SOP for Deviation Trending: A Missed Opportunity in GMP Oversight” »

Deviation Handling, GMP Audit Findings

Undefined Root Cause Analysis in SOPs: A Major Deviation Risk

Posted on By

Undefined Root Cause Analysis in SOPs: A Major Deviation Risk Why SOPs Must Define Root Cause Analysis Processes in GMP Systems Introduction to the Audit Finding 1. Nature of the Finding When SOPs related to deviation handling, OOS, or complaint investigations lack a defined root cause analysis (RCA) method, investigations become inconsistent and unreliable. 2….

Read More “Undefined Root Cause Analysis in SOPs: A Major Deviation Risk” »

Deviation Handling, GMP Audit Findings

Deviations Closed Without QA Approval: A Major GMP Oversight

Posted on By

Deviations Closed Without QA Approval: A Major GMP Oversight Why QA Must Always Approve Deviation Closures in GMP Systems Introduction to the Audit Finding 1. Issue Overview Deviations being closed without review or approval by the Quality Assurance (QA) department is a critical GMP failure that compromises product quality and compliance oversight. 2. Context in…

Read More “Deviations Closed Without QA Approval: A Major GMP Oversight” »

Deviation Handling, GMP Audit Findings

Posts pagination

Previous 1 … 7 8 9 … 12 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme